Articles

Softening U.S. dollar largely erases 2024 gain as investors expect Fed rate cuts

The U.S. dollar has softened this quarter, wiping out its 2024 gains as traders expect the Federal Reserve may soon begin easing its monetary policy via interest-rate cuts.

‘I want to meet someone rich’: Are dating apps a hotbed of upwardly-mobile singletons in search of wealthy partners?

Tinder, Hinge, The League and Raya are marketing tools for status-conscious Americans, and it’s a crowded space.

What Friday’s jobs report could mean for bitcoin’s next move

A weekly look at the most important news and moves in crypto, and what’s on the horizon in digital assets.

Richard Branson says business leaders must join the fight to end ‘brutal’ and ‘deeply flawed’ death penalty

“It’s about good governance and efficiency,” the Virgin Galactic founder told MarketWatch.

We spent 10 amazing weeks in Europe living on just our Social Security budget. Here’s how we did it.

How to pull off a fabulous trip without going into debt — or only staying in hostels.

Trump’s proposal to cover IVF costs has no chance of passing Congress, analyst says

Donald Trump’s proposal to eliminate out-of-pocket costs for in vitro fertilization is facing skepticism, with one veteran analyst saying it would be dead on arrival in Congress.

Centene’s Medicaid pressures weigh on stocks of major insurers

Shares of major players in the Medicaid business dropped sharply Wednesday after Centene Corp. executives spoke about ongoing tumult in the joint federal and state program.

Sweetgreen’s 2024 rally stays fresh as TD Cowen upgrades salad chain to buy

Investors continued flocking to Sweetgreen Inc.’s hot stock on Wednesday as the restaurant chain piled on more gains on the heels of a fresh upgrade to buy from hold at TD Cowen.

Philadelphia Fed President Patrick Harker to retire next June

Philadelphia Federal Reserve President Patrick Harker will retire next June, the regional Fed bank announced Wednesday.

Super Micro’s stock just got downgraded for these four reasons

Barclays worries about three trends in the server maker’s business, plus inadequate investor transparency.

Moderna’s experimental mpox vaccine reduces severity of disease, early study finds  

Amid mounting concerns about the spread of mpox, an experimental vaccine from Moderna may be poised to offer additional protection beyond currently available vaccines, research published Wednesday shows. 

Factory orders rise in July after two months of weakness

Orders for U.S. manufactured goods rose 5% in July, the Commerce Department said Wednesday.  The gain follows two straight monthly declines.
1 1,019 1,020 1,021 1,022 1,023 2,525